Nova EYE Medical Ltd (EYE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has a cash flow conversion efficiency ratio of -0.059x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-846.00K ≈ $-598.60K USD) by net assets (AU$14.28 Million ≈ $10.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EYE company net worth for the company's overall valuation and market capitalisation.
Nova EYE Medical Ltd - Cash Flow Conversion Efficiency Trend (1992–2026)
This chart illustrates how Nova EYE Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nova EYE Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nova EYE Medical Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Nova EYE Medical Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Camellia Metal Co Ltd
TWO:2064
|
0.107x |
|
Bonasudden Holding AB
ST:BONAS
|
-0.006x |
|
Hansol Pns
KO:010420
|
0.036x |
|
Sangji Caelum Inc
KQ:042940
|
-0.059x |
|
Renovaro Biosciences Inc
NASDAQ:RENB
|
0.085x |
|
Hilbert Group AB Series B
ST:HILB-B
|
-0.485x |
|
Thai O.P.P. Public Company Limited
BK:TOPP
|
0.030x |
|
CompuLab Ltd
TA:CLAB
|
0.080x |
Annual Cash Flow Conversion Efficiency for Nova EYE Medical Ltd (1992–2026)
The table below shows the annual cash flow conversion efficiency of Nova EYE Medical Ltd from 1992 to 2026. View EYE stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | AU$14.28 Million ≈ $10.10 Million |
AU$-3.12 Million ≈ $-2.21 Million |
-0.219x | +32.55% |
| 2025-06-30 | AU$18.97 Million ≈ $13.42 Million |
AU$-6.15 Million ≈ $-4.35 Million |
-0.324x | +11.97% |
| 2024-06-30 | AU$21.33 Million ≈ $15.09 Million |
AU$-7.86 Million ≈ $-5.56 Million |
-0.368x | -27.10% |
| 2023-06-30 | AU$23.19 Million ≈ $16.41 Million |
AU$-6.72 Million ≈ $-4.76 Million |
-0.290x | -88.11% |
| 2022-06-30 | AU$30.40 Million ≈ $21.51 Million |
AU$-4.68 Million ≈ $-3.31 Million |
-0.154x | +58.58% |
| 2021-06-30 | AU$35.34 Million ≈ $25.00 Million |
AU$-13.14 Million ≈ $-9.30 Million |
-0.372x | -786.28% |
| 2020-06-30 | AU$100.59 Million ≈ $71.17 Million |
AU$5.45 Million ≈ $3.86 Million |
0.054x | +188.64% |
| 2019-06-30 | AU$68.80 Million ≈ $48.68 Million |
AU$-4.21 Million ≈ $-2.98 Million |
-0.061x | -958.05% |
| 2018-06-30 | AU$73.24 Million ≈ $51.82 Million |
AU$522.00K ≈ $369.35K |
0.007x | +111.61% |
| 2017-06-30 | AU$56.93 Million ≈ $40.28 Million |
AU$-3.50 Million ≈ $-2.47 Million |
-0.061x | -156.81% |
| 2016-06-30 | AU$48.26 Million ≈ $34.14 Million |
AU$5.22 Million ≈ $3.69 Million |
0.108x | -37.57% |
| 2015-06-30 | AU$39.79 Million ≈ $28.16 Million |
AU$6.89 Million ≈ $4.88 Million |
0.173x | +136.60% |
| 2014-06-30 | AU$36.95 Million ≈ $26.14 Million |
AU$2.70 Million ≈ $1.91 Million |
0.073x | +16.05% |
| 2013-06-30 | AU$30.83 Million ≈ $21.81 Million |
AU$1.94 Million ≈ $1.38 Million |
0.063x | +10.04% |
| 2012-06-30 | AU$32.06 Million ≈ $22.68 Million |
AU$1.84 Million ≈ $1.30 Million |
0.057x | +777.54% |
| 2011-06-30 | AU$30.32 Million ≈ $21.45 Million |
AU$198.00K ≈ $140.10K |
0.007x | -95.38% |
| 2010-06-30 | AU$33.19 Million ≈ $23.48 Million |
AU$4.69 Million ≈ $3.32 Million |
0.141x | +6.79% |
| 2009-06-30 | AU$30.05 Million ≈ $21.26 Million |
AU$3.98 Million ≈ $2.81 Million |
0.132x | +633.47% |
| 2008-06-30 | AU$47.94 Million ≈ $33.92 Million |
AU$-1.19 Million ≈ $-841.29K |
-0.025x | -155.72% |
| 2007-06-30 | AU$43.38 Million ≈ $30.69 Million |
AU$1.93 Million ≈ $1.37 Million |
0.045x | +79.61% |
| 2006-06-30 | AU$35.14 Million ≈ $24.87 Million |
AU$871.00K ≈ $616.29K |
0.025x | +124.26% |
| 2005-06-30 | AU$28.99 Million ≈ $20.51 Million |
AU$-2.96 Million ≈ $-2.10 Million |
-0.102x | -358.55% |
| 2004-06-30 | AU$30.48 Million ≈ $21.57 Million |
AU$1.20 Million ≈ $851.91K |
0.040x | -55.72% |
| 2003-06-30 | AU$30.59 Million ≈ $21.64 Million |
AU$2.73 Million ≈ $1.93 Million |
0.089x | +370.50% |
| 2002-06-30 | AU$30.81 Million ≈ $21.80 Million |
AU$-1.02 Million ≈ $-718.88K |
-0.033x | +94.34% |
| 2001-06-30 | AU$789.86K ≈ $558.88K |
AU$-460.00K ≈ $-325.48K |
-0.582x | -305.46% |
| 1997-06-30 | AU$1.64 Million ≈ $1.16 Million |
AU$-235.77K ≈ $-166.82K |
-0.144x | -8.88% |
| 1996-06-30 | AU$1.72 Million ≈ $1.21 Million |
AU$-226.28K ≈ $-160.11K |
-0.132x | -91.37% |
| 1995-06-30 | AU$1.20 Million ≈ $851.91K |
AU$-83.00K ≈ $-58.73K |
-0.069x | +84.18% |
| 1994-06-30 | AU$280.00K ≈ $198.12K |
AU$-122.00K ≈ $-86.32K |
-0.436x | +28.94% |
| 1993-06-30 | AU$486.00K ≈ $343.88K |
AU$-298.00K ≈ $-210.85K |
-0.613x | -15.03% |
| 1992-06-30 | AU$741.00K ≈ $524.30K |
AU$-395.00K ≈ $-279.49K |
-0.533x | -- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more